Previous studies have shown that ICP regulators, such as PD-L1 and TIM3, and ICD regulators, such as CALR and HMGB1, play critical roles in regulating host anti-tumor immunity and thus affect the efficacy of mRNA vaccines. Here, HAVCR2 is linked to neoplasm.